and 8 (OHED) consisted of chicks from old hens fed diets similar to those given to YH in treatments 1, 2, 3, and 4, respectively. Growth performance (body weight gain and feed conversion ratio) was evaluated on d 7 and 14. Intestinal tissue samples were also analyzed for alkaline phosphatase (ALP) activity as an indicator of intestinal maturation on d 4 and 13 of experiment. Results showed that by d 14 of experiment, only BMD treatments (YHB and OHB) improved body weight gain (P < 0.05). However, the body weight gains of chicks in the yeast-supplemented treatments (YHE, YHED, OHE, and OHED) were statistically similar (P > 0.05) to those of the BMD treatments. Ileal ALP activity was consistently enhanced by BMD and yeast product supplemented at 0.075% of the diet. It was concluded that antibiotic BMD and our novel yeast product supplemented at 0.075% of the diet improved early chick growth and maturation of the ileal segment of the small intestine.
investigated for use as alternatives to AGP, but none so far have been effective enough to fully replace AGP. Thus, it remains crucial to identify a fully effective, nonantibiotic supplement (or a suitable combination) that can completely replace the use of AGP.
Yeast products are nonantibiotic functional products that are naturally obtained from yeast strains such as Saccharomyces cerevisiae and Kloeckera apiculata (Owens and McCracken, 2007) . Although the composition of yeast products varies, they essentially contain nucleotides and β-glucans that enhance intestinal maturation and immune function, respectively (Solis de los Morales-López et al., 2010) . In poultry, the efficacy of yeast products as alternatives to AGP has produced inconsistent results. For instance, in some studies, yeast was found to improve feed utilization and BW in broiler chickens (Madrigal et al., 1993) and turkey poults (Bradley et al., 1994) . On the hand, Morales-López et al. (2009) evaluated the effect of various yeast cell wall components on growth performance parameters in broiler chicks, but found no effect. Perhaps the components of a yeast product influence the efficacy of yeast (and yeast-containing products) as growth promoters, and, if so, each yeast product formulation must be evaluated for efficacy as a nonantibiotic AGP.
A novel yeast product formulation (comprising dehydrated distillers grains, torula yeast, fermented Aspergillus oryzae, and Bacillus subtilis; Oshawa Specialty Products, Oshawa, Ontario, Canada) may enhance early intestinal development and growth, especially in chicks obtained from young breeder hens. According to Huff et al. (2007) , it is important to consider breeder hen age when designing studies to evaluate nonantibiotic alternatives to AGP, and when making decisions to incorporate such alternatives into any facet of production . Thus, the goal of this study was to compare the efficacy of a novel yeast formulation to bacitracin methylene disalicylate (BMD), an AGP, in enhancing early chick growth and intestinal maturation in broiler chicks obtained from breeder hens of different ages.
MATERIALS AND METHODS
All the procedures used in this study were approved by the Auburn University Institutional Animal Care and Use Committee.
Experimental Animals and Treatments
Three hundred eighty-four male broiler chicks (Ross × Ross 708) comprising 192 chicks from young breeder hens (26-27 wk of age) and 192 chicks from old breeder hens (58-59 wk of age) were obtained from a commercial hatchery and transported to the Auburn University Poultry Research Farm (Auburn, AL) for experimentation. Upon arrival, chicks were weighed, wing-banded, and randomly assigned to 1 of 8 dietary treatments. Treatment 1 (YH) included chicks, from young hens, fed a control diet (Table 1) consisting of corn-soybean meal (SBM) basal without BMD or yeast product added. Treatment 2 (YHB) consisted of chicks, from young hens, fed the bacitracin diet (Table 1) consisting of corn-SBM basal into which BMD was added at 0.055 g/kg. Treatment 3 (YHE) consisted of chicks, from young hens, fed the 1× yeast diet consisting of corn-SBM basal into which a novel yeast product (made from dehydrated distillers grains, torula yeast, fermented Aspergillus oryzae, and Bacillus subtilis; Oshawa Specialty Products) was added at 0.075%. Treatment 4 (YHED) consisted of chicks, from young hens, fed the 2× yeast diet (Table 1) consisting of corn-SBM basal into which yeast product was added at 0.15%, twice the amount of yeast product included in treatment 3. Treatments 5 (OH), 6 (OHB), 7 (OHE), and 8 (OHED) consisted of chicks from old hens fed diets similar to those given in treatments 1, 2, 3, and 4, respectively. Each experimental treatment consisted of 4 replicate pens with 12 chicks per pen. All pens were in Petersime raised wire batteries (Petersime, Gettysburg, OH) maintained at 30°C ± 2°C during the first week, after which temperature was gradually decreased weekly by 2°C. Continuous lighting and access to feed and water were provided throughout the experiment. Experimental diets (Table 1) were formulated to meet the recommendations of the National Research Council (1994). Duration of experiment was 2 wk.
Assessment of Growth Performance
On a weekly basis, BW and BW gain of each chick was recorded, and feed conversion ratio (FCR) was calculated. Mortality was recorded daily.
Assessing Early Intestinal Development by Determining Alkaline Phosphatase Activity
Early intestinal development was assessed by measuring intestinal alkaline phosphatase (ALP) activity. Intestinal ALP is a membrane-bound glycoprotein that hydrolyzes a wide variety of monophosphate esters at an alkaline pH optimum . Because intestinal ALP is commonly used as a marker of enterocyte maturation (Uni et al., 2000; Iji et al., 2001; Jeurissen et al., 2002; Hinnebusch et al., 2004) , changes in its activity levels can be used as an indirect indicator of enterocyte or intestinal maturation.
To collect intestinal tissue samples for ALP analyses, on d 4 and 13 of experiment, 2 chicks were randomly taken from each pen (totaling 8 chicks per treatment) and killed by CO 2 asphyxiation. Thereafter, the intestine of each chick was aseptically excised and placed on ice, and a 1-cm tissue section was taken from each segment (duodenum, jejunum, and ileum) of the small intestine. Each tissue section was rinsed twice in PBS (Fisher Scientific, Fair Lawn, NJ) to remove the intestinal digesta, snap-frozen in liquid N 2 , and kept at -70°C until time to determine ALP activity.
To determine ALP activity, previously frozen tissue sections were thawed on ice and 350 mg of each tissue was homogenized in 7 mL of 50 mM sodium phosphate buffer (Fisher Scientific) containing 0.5% Triton X-100 (Fisher Biotech, Fair Lawn, NJ). The resulting homogenate was then centrifuged at 10,000 × g (Sorvall Legend 23R, Thermo Fisher Scientific, Waltham, MA) for 15 min at 4°C, and the supernatant was collected for estimation of protein (Quick Start Bradford Protein Assay, Bio-Rad, Hercules, CA) and ALP activity (Quantichrome Alkaline phosphatase assay kit, BioAssay Systems, Hayward, CA). The assay utilized stable p-nitrophenol phosphate as substrate, and ALP activity was expressed as international units per milligram of protein.
Statistical Analysis
The experimental unit for all data was pen average. Data for growth performance (BW, BW gain, FCR, and mortality) and intestinal ALP activity were analyzed by ANOVA using the mixed model procedure of SAS (SAS Institute, 2004) . Fixed effects for analyses were hen age (young vs. old) and dietary treatments (no feed additive vs. BMD supplementation vs. 1× yeast product supplementation vs. 2× yeast product supplementation). The fixed effects described and variable effects (BW, BW gain, FCR, mortality, and ALP activity) were subjected to a 2 × 4 factorial arrangement before analyses. In addition, mortality data were subjected to arcsine square root transformation before analysis. Differences of least squares means (TukeyKramer) were used to detect differences among means. Data are presented as means ± SEM and statements of statistical significance were based upon P < 0.05.
RESULTS AND DISCUSSION
Results for chick growth performance are presented in Tables 2 and 3 . On d 7 of the experiment, dietary treatment affected BW, BW gain, and FCR of chicks, whereas breeder hen age affected only BW and BW gain (Table 2) . Throughout this study, young hen chicks in the control treatment had lower BW and BW gain (P < 0.05) compared with old hen chicks in the control treatment (Tables 2 and 3 ). Similarly, from 1 to 21 d of age, Schaefer et al. (2006) observed that the BW of poults hatched from young (33-wk-old) breeder hens was lower (P < 0.05) than that of poults hatched from older (55-wk-old) breeder hens.
In regard to dietary treatment effects, on d 7 of the experiment, supplementing the diet of young hen chicks with antibiotic BMD (YHB treatment) or yeast product (YHE and YHED treatments) had no effect on chick growth, but improved FCR (P < 0.05) compared with the control treatment in young hen chicks (Table 2 ). In contrast, supplementing the diet of old hen chicks with either antibiotic BMD (OHB treatment) or 0.075% yeast product (OHE treatment) improved BW, BW gain, and FCR (P < 0.05) compared with the control treatment in old hen chicks, whereas the 0.15% yeast supplementation (OHED) did not have a consistent effect on growth performance (Table 2) . On d 14 of the experiment (Table 3) , among young hen chicks, only chicks in YHB had higher BW and BW gain (P < 0.05) compared with the control YH treatment. However, at the same time, BW gain of YHB chicks was statistically similar (P > 0.05) to that of chicks in YHE and YHED (Table 3) . A similar trend in BW and BW gain was observed for old hen chicks (Table 3) . The FCR for all treatments were similar by d 14 of experiment (P > 0.05; Table 3 ). Our finding that the yeast product evaluated in this study enhanced the growth performance of chicks on d 7 of the experiment is supported by the work of Gao et al. (2008) . Gao and colleagues (2008) supplemented a yeast culture product into the 1 YH and OH = chicks from young and old hens, respectively, given the basal corn-soybean meal (SBM) diet and no additives (control); YHB and OHB = given SBM containing bacitracin methylene disalicylate at 0.055 g/kg; YHE and OHE = given SBM containing yeast product at 0.075% (wt/wt); and YHED and OHED = given SBM containing yeast product at 0.15% (wt/wt).
2 Values are based only on weight of live birds. 3 FCR = feed conversion ratio calculated as feed-to-gain ratio and adjusted for mortality by including the gains of dead birds in the calculations. 4 Young breeder hens were 26 to 27 wk of age; old breeder hens were 58 to 59 wk of age. a-e Mean values bearing different superscript letters within a column are significantly different (P < 0.05). 1 YH and OH = chicks from young and old hens, respectively, given the basal corn-soybean meal (SBM) diet and no additives (control); YHB and OHB = given SBM containing bacitracin methylene disalicylate at 0.055 g/kg; YHE and OHE = given SBM containing yeast product at 0.075% (wt/wt); and YHED and OHED = given SBM containing yeast product at 0.15% (wt/wt).
3 FCR = feed conversion ratio calculated as feed-to-gain ratio and adjusted for mortality by including the gains of dead birds in the calculations. 4 Young breeder hens were 26 to 27 wk of age; old breeder hens were 58 to 59 wk of age.
diets of broiler chicks at 0, 0.25, 0.50, and 0.75% from 1 to 42 d and found that supplementing the yeast culture at 0.25% of the diet improved BW gain and FCR (P < 0.05) throughout the experiment. Total mortality for the current experiment was 1.56%, and no differences were observed among treatments (P = 0.6940). The small intestine is the primary site for nutrient assimilation, and dietary support is central to gut maturation (differentiation), development, and continued function (Pácha, 2000) . Furthermore, continuous proliferation, migration, differentiation, and maturation of intestinal crypt stem cells is regulated by a variety of factors, which include luminal nutrients (Uni et al., 2001 ) such as the BMD and yeast product added into the diet of chicks in this experiment. The effect of yeast product and BMD on intestinal maturation as assessed by ALP activity is presented in Figures 1, 2 , and 3. On d 4 of the experiment, duodenal ALP activity was similar (P > 0.05) for all treatments (Figure 1) , whereas the effect of dietary supplemented yeast product or BMD on jejunal ALP was inconsistent or staggered ( Figure  2 ). However, in the ileum, differences in ALP activity were observed among treatments (Figure 3) . Specifically, among young hen chicks (YH, YHB, YHE, and YHED), the BMD-and yeast product-supplemented treatments (YHB, YHE, and YHED) had higher ileal ALP activity (P < 0.05) compared with the control YH treatment (Figure 3) , indicating an enhancement in the maturation of cells in the ileum. Similarly, among old hen chicks, BMD-and yeast product-supplemented at 0.075% treatments (OHB and OHE, respectively) had higher ALP activity (P < 0.05) compared with the control OH treatment (Figure 3) . The improvement in the FCR of young hen chicks (YHB, YHE, and YHED) and the improvement in the BW, BW gain, and FCR of old (2007) assessed intestinal maturation in broiler chicks by measuring mucosal morphological parameters such as villus height, villus surface area, lamina propria thickness, and crypt depth as indices of epithelial maturation. They observed that Alphamune supplementation had no effect on duodenum epithelial morphology, had mixed (or inconclusive effects) on jejunal morphology, and significantly influenced only ileal morphology, as observed in this study with our yeast product and BMD. Specifically, they observed that dietary supplementation of Alphamune at up to 2% of the diet enhanced villus height, villus surface area, lamina propria thickness, and crypt depth in the ileum at 7 and 21 d (P < 0.05) of the experiment.
Another interesting point from previous reports is that the effective inclusion levels reported for a yeast culture (0.25%; Gao et al., 2008) and Alphamune yeast extract (2%; Solis de los are different from the 0.075% level observed to be effective for the novel yeast product used in this study. This finding reinforces the need to evaluate the efficacy of every yeast product for its intended use before inclusion in poultry or animal diets.
In summary, we compared the efficacy of a novel yeast product and BMD in enhancing early growth and intestinal maturation in broiler chicks from breeder hens of different ages. Results from this study showed that chicks from young hens had lesser BW (P < 0.05) compared with chicks from older hens. During the first week of life, chicks from young hens effectively utilized both BMD and yeast product (supplemented at up to 0.15% level of the diet) for improving FCR (P < 0.05; Table 2 ). In addition to the improvement in FCR, chicks from old hens effectively utilized both BMD and yeast product (supplemented at 0.075% level of the diet) to improve BW and BW gain (Table 2) . However, by d 14 of experiment, BMD was most effective in enhancing growth of chicks from both young and old hens (Table  3) . Ileal ALP activity (epithelial maturation) was consistently enhanced by BMD supplementation and yeast product supplemented at 0.075% level of the diet in both young and old hen chicks, whereas yeast product supplemented at 0.15% level had an inconsistent effect (Figure 4 ). We concluded that antibiotic BMD and yeast product supplemented at 0.075% level of the diet improved early chick growth and ileal (intestinal) maturation. . Effect of yeast product and bacitracin methylene disalicylate on jejunal alkaline phosphatase (ALP) activity in chicks at 13 d of age. YH and OH = chicks from young and old hens, respectively, given the basal corn-soybean meal (SBM) diet and no additives (control); YHB and OHB = given SBM containing bacitracin methylene disalicylate at 0.055 g/kg; YHE and OHE = given SBM containing yeast product at the 0.075% (wt/wt) level; and YHED and OHED = given SBM containing yeast product at the 0.15% (wt/wt) level. Bars equal means ± SEM, n = 8; P < 0.05. Color version available in the online PDF.
